Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

PMID: 33882206
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2021
Reference: N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485.
Impact factor: 91.253
Publication type: Paper in international publication
Authors: Dalenc, Florence, Schmid, Peter, Carey, Lisa A, Gianni, Luca, Piccart, Martine J, Loibl, Sibylle, Goldenberg, David M, Hong, Quan, Olivo, Martin S, Itri, Loretta M et al.
DOI: 10.1056/NEJMoa2028485

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

PMID: 33882206
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2021
Reference: N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485.
Impact factor:
Publication type: Paper in international publication
Authors: Ademuyiwa, Foluso; Aftimos, Philippe; Aftimos, Philippe; Armstrong, Anne; Bardia, Aditya; Bardia, Aditya; Becker, Becker; Bigot, Frederic; Brufsky, Adam; Brufsky, Adam et al.
DOI: 10.1056/NEJMoa2028485

Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.

PMID: 34911534
Journal: BMC Medical Informatics and Decision Making
Year: 2021
Reference: BMC Med Inform Decis Mak. 2021 Dec 15;21(1):349. doi: 10.1186/s12911-021-01710-8.
Impact factor: 2.796
Publication type: Paper in international publication
Authors: Pons-Mesquida, M Angels, Oms-Arias, Miriam, Diogene-Fadini, Eduard, Figueras, Albert et al.
DOI: 10.1186/s12911-021-01710-8

Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.

PMID: 34911534
Journal: BMC Medical Informatics and Decision Making
Year: 2021
Reference: BMC Med Inform Decis Mak. 2021 Dec 15;21(1):349. doi: 10.1186/s12911-021-01710-8.
Impact factor:
Publication type: Paper in international publication
Authors: Diogene-Fadini, Eduard; Figueras, Albert; Oms-Arias, Miriam; Pons-Mesquida, M Angels et al.
DOI: 10.1186/s12911-021-01710-8

Safety and activity of the TGFbeta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.

PMID: 33688022
Journal: Journal for ImmunoTherapy of Cancer
Year: 2021
Reference: J Immunother Cancer. 2021 Mar;9(3). pii: jitc-2020-002068. doi: 10.1136/jitc-2020-002068.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Melisi, Davide, Oh, Do-Youn, Hollebecque, Antoine, Calvo, Emiliano, Varghese, Anna, Borazanci, Erkut, Macarulla, Teresa, Merz, Valeria, Zecchetto, Camilla, Zhao, Yumin et al.
DOI: 10.1136/jitc-2020-002068

Safety and activity of the TGFbeta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.

PMID: 33688022
Journal: Journal for ImmunoTherapy of Cancer
Year: 2021
Reference: J Immunother Cancer. 2021 Mar;9(3). pii: jitc-2020-002068. doi: 10.1136/jitc-2020-002068.
Impact factor:
Publication type: Paper in international publication
Authors: Avsar, Emin; Benhadji, Karim A; Borazanci, Erkut; Calvo, Emiliano; Estrem, Shawn T; Gandhi, Leena; Garcia-Carbonero, Rocio; Guba, Susan C; Gueorguieva, Ivelina; Hollebecque, Antoine et al.
DOI: 10.1136/jitc-2020-002068

Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.

PMID: 33880650
Journal: EUROPEAN JOURNAL OF PEDIATRICS
Year: 2021
Reference: Eur J Pediatr. 2021 Sep;180(9):3029-3038. doi: 10.1007/s00431-021-04063-6. Epub 2021 Apr 20.
Impact factor: 3.183
Publication type: Paper in international publication
Authors: Carrillo-Palau, Marta, Ros-Arnal, Ignacio, Rodriguez-Martinez, Alejandro, Escartin-Madurga, Laura, Gutierrez-Junquera, Carolina, Vicente-Santamaria, Saioa, Velasco Rodriguez-Belvis, Marta, Fernandez-Fernandez, Sonia, Alberto-Alonso, Jose Ramon, Montraveta, Montserrat et al.
DOI: 10.1007/s00431-021-04063-6

Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.

PMID: 33880650
Journal: EUROPEAN JOURNAL OF PEDIATRICS
Year: 2021
Reference: Eur J Pediatr. 2021 Sep;180(9):3029-3038. doi: 10.1007/s00431-021-04063-6. Epub 2021 Apr 20.
Impact factor:
Publication type: Paper in international publication
Authors: Alberto-Alonso, Jose Ramon; Carrillo-Palau, Marta; Donat-Aliaga, Ester; Escartin-Madurga, Laura; Fernandez-Fernandez, Sonia; Garcia-Romero, Ruth; Gutierrez-Junquera, Carolina; Irastorza-Terradillos, Inaki; Martin de Carpi, Javier; Martinez de Zabarte Fernandez, Jose Miguel et al.
DOI: 10.1007/s00431-021-04063-6

Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.

PMID: 32805330
Journal: INTERNATIONAL JOURNAL OF CARDIOLOGY
Year: 2021
Reference: Int J Cardiol. 2021 Jan 1;322:129-134. doi: 10.1016/j.ijcard.2020.08.034. Epub 2020 Aug 14.
Impact factor:
Publication type: Paper in international publication
Authors: Aboulhosn, Jamil; Alonso-Gonzalez, Rafael; Bouchardy, Judith; Bouma, Berto J; Broberg, Craig S; Budts, Werner; Dimopoulos, Konstantinos; Egbe, Alexander C; Fernandes, Susan M; Fusco, Flavia et al.
DOI: 10.1016/j.ijcard.2020.08.034

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.

PMID: 33605445
Journal: BRITISH JOURNAL OF HAEMATOLOGY
Year: 2021
Reference: Br J Haematol. 2021 Apr;193(2):325-338. doi: 10.1111/bjh.17326. Epub 2021 Feb 19.
Impact factor: 6.998
Publication type: Paper in international publication
Authors: Stilgenbauer, Stephan, Bosch, Francesc, Ilhan, Osman, Kisro, Jens, Mahe, Beatrice, Mikuskova, Eva, Osmanov, Dzhelil, Reda, Gianluigi, Robinson, Sue, Tausch, Eugen et al.
DOI: 10.1111/bjh.17326

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.

PMID: 33605445
Journal: BRITISH JOURNAL OF HAEMATOLOGY
Year: 2021
Reference: Br J Haematol. 2021 Apr;193(2):325-338. doi: 10.1111/bjh.17326. Epub 2021 Feb 19.
Impact factor:
Publication type: Paper in international publication
Authors: Bosch, Francesc; Bottcher, Sebastian; Foa, Robin; Ilhan, Osman; Kisro, Jens; Leblond, Veronique; Mahe, Beatrice; Mikuskova, Eva; Osmanov, Dzhelil; Perretti, Thomas et al.
DOI: 10.1111/bjh.17326

Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.

PMID: 34788858
Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION
Year: 2021
Reference: Nephrol Dial Transplant. 2021 Nov 12. pii: 6426121. doi: 10.1093/ndt/gfab313.
Impact factor: 5.992
Publication type: Paper in international publication
Authors: Millan, Juan Carlos Ruiz San, Toapanta, Nestor, Gracia-Iguacel, Carolina, Cervera, Maria Cinta Aguilar, Lara, Noelia Balibrea, Leyva, Alba, Rojas, Jose, Gansevoort, Ron T, de Sequera, Patricia, Ramos, Patricia Munoz et al.
DOI: 10.1093/ndt/gfab313

Safety, diagnostic, and therapeutic value of flexible bronchoscopy in critically ill COVID-19 patients.

PMID: 33367993
Journal: Canadian Journal of Anesthesia-Journal canadien d anesthesie
Year: 2021
Reference: Can J Anaesth. 2021 Mar;68(3):434-435. doi: 10.1007/s12630-020-01887-y. Epub 2020 Dec 24.
Impact factor: 5.063
Publication type: Letter or abstract
Authors: Loor, Karina, Alvarez, Antonio, Felipe Montiel, Almudena, Ferrer, Ricard, Roca, Oriol, Garcia-de-Acilu, Marina, Clofent, David, Landivar, Jose Cardoso, Polverino, Eva, Culebras Amigo, Mario et al.
DOI: 10.1007/s12630-020-01887-y

Safety, diagnostic, and therapeutic value of flexible bronchoscopy in critically ill COVID-19 patients.

PMID: 33367993
Journal: Canadian Journal of Anesthesia-Journal canadien d anesthesie
Year: 2021
Reference: Can J Anaesth. 2021 Mar;68(3):434-435. doi: 10.1007/s12630-020-01887-y. Epub 2020 Dec 24.
Impact factor:
Publication type: Letter or abstract
Authors: Alvarez, Antonio; Clofent, David; Culebras Amigo, Mario; Felipe Montiel, Almudena; Ferrer, Ricard; Garcia-de-Acilu, Marina; Landivar, Jose Cardoso; Loor, Karina; Loor, Karina; Polverino, Eva et al.
DOI: 10.1007/s12630-020-01887-y

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

PMID: 34654536
Journal: NEUROLOGIA
Year: 2021
Reference: Neurologia. 2021 Oct;36(8):611-617. doi: 10.1016/j.nrleng.2021.03.005.
Impact factor:
Publication type: Paper in national publication
Authors: Alpuente, A; Caronna, E; Gago-Veiga, A B; Irimia Sieira, P; Jose Gallardo, V; Lopez-Bravo, A; Lopez-Veloso, A C; Porta-Etessam, J; Pozo-Rosich, P; Sanchez-Mateo, N M et al.
DOI: 10.1016/j.nrl.2021.03.003

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

PMID: 33832802
Journal: NEUROLOGIA
Year: 2021
Reference: Neurologia (Engl Ed). 2021 Mar 19. pii: S0213-4853(21)00056-6. doi: 10.1016/j.nrl.2021.03.003.
Impact factor: 3.109
Publication type: Paper in national publication
Authors: Caronna, E, Jose Gallardo, V, Alpuente, A, Torres-Ferrus, M, Sanchez-Mateo, N M, Viguera-Romero, J, Lopez-Veloso, A C, Lopez-Bravo, A, Gago-Veiga, A B, Irimia Sieira, P et al.
DOI: 10.1016/j.nrl.2021.03.003

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

PMID: 33832802
Journal: NEUROLOGIA
Year: 2021
Reference: Neurologia (Engl Ed). 2021 Mar 19;36(8):611-7. doi: 10.1016/j.nrl.2021.03.003.
Impact factor:
Publication type: Paper in international publication
Authors: Alpuente, A; Caronna, E; Gago-Veiga, A B; Irimia Sieira, P; Jose Gallardo, V; Lopez-Bravo, A; Lopez-Veloso, A C; Porta-Etessam, J; Pozo-Rosich, P; Sanchez-Mateo, N M et al.
DOI: 10.1016/j.nrl.2021.03.003

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

PMID: 34775302
Journal: ESMO Open
Year: 2021
Reference: ESMO Open. 2021 Dec;6(6):100300. doi: 10.1016/j.esmoop.2021.100300. Epub 2021 Nov 12.
Impact factor: 6.54
Publication type: Paper in international publication
Authors: Di Meglio, A, Condorelli, M, Bruzzone, M, Ceppi, M, Ferrari, A, Grinshpun, A, Hamy, A S, de Azambuja, E, Carrasco, E, Peccatori, F A et al.
DOI: 10.1016/j.esmoop.2021.100300

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

PMID: 34775302
Journal: ESMO Open
Year: 2021
Reference: ESMO Open. 2021 Dec;6(6):100300. doi: 10.1016/j.esmoop.2021.100300. Epub 2021 Nov 12.
Impact factor:
Publication type: Paper in international publication
Authors: Ameye, L; Azim, H A; Balmana, J; Blondeaux, E; Bruzzone, M; Caron, O; Carrasco, E; Ceppi, M; Clatot, F; Condorelli, M et al.
DOI: 10.1016/j.esmoop.2021.100300

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.

PMID: 34475123
Journal: NEUROLOGY
Year: 2021
Reference: Neurology. 2021 Oct 19;97(16):e1546-e1559. doi: 10.1212/WNL.0000000000012700. Epub 2021 Sep 2.
Impact factor:
Publication type: Paper in international publication
Authors: Chognot, Cathy; Craveiro, Licinio; Hauser, Stephen L; Hughes, Richard; Kappos, Ludwig; Koendgen, Harold; Montalban, Xavier; Pasquarelli, Noemi; Pradhan, Ashish; Prajapati, Kalpesh et al.
DOI: 10.1212/WNL.0000000000012700

Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.

PMID: 33638257
Journal: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Year: 2021
Reference: J Clin Pharm Ther. 2021 Aug;46(4):1062-1070. doi: 10.1111/jcpt.13394. Epub 2021 Feb 26.
Impact factor: 2.512
Publication type: Paper in international publication
Authors: Jimenez-Lozano, Ines, Caro-Teller, Jose Manuel, Fernandez-Hidalgo, Nuria, Miarons, Marta, Frick, Marie Antoinette, Batllori Badia, Emma, Serrano, Berta, Parramon-Teixido, Carlos Javier, Camba-Longueira, Fatima, Moral-Pumarega, Maria Teresa et al.
DOI: 10.1111/jcpt.13394

Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.

PMID: 33638257
Journal: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Year: 2021
Reference: J Clin Pharm Ther. 2021 Aug;46(4):1062-1070. doi: 10.1111/jcpt.13394. Epub 2021 Feb 26.
Impact factor:
Publication type: Paper in international publication
Authors: Batllori Badia, Emma; Cabanas Poy, Maria Josep; Camba-Longueira, Fatima; Caro-Teller, Jose Manuel; Fernandez-Hidalgo, Nuria; Frick, Marie Antoinette; Gorgas Torner, Maria Queralt; Jimenez-Lozano, Ines; Miarons, Marta; Moral-Pumarega, Maria Teresa et al.
DOI: 10.1111/jcpt.13394

Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.

PMID: 34694589
Journal: DRUG SAFETY
Year: 2021
Reference: Drug Saf. 2021 Dec;44(12):1375-1390. doi: 10.1007/s40264-021-01121-8. Epub 2021 Oct 25.
Impact factor:
Publication type: Paper in international publication
Authors: Cinconze, Elisa; Eckermann, Tamara; Godderis, Lode; Lu, Emily; Martinez-Gomez, Xavier; Nwoji, Ugo; Salamanca de la Cueva, Ignacio; Wang, Huajun; Yanni, Emad et al.
DOI: 10.1007/s40264-021-01121-8

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

PMID: 33676590
Journal: Lancet Respiratory Medicine
Year: 2021
Reference: Lancet Respir Med. 2021 May;9(5):522-532. doi: 10.1016/S2213-2600(21)00099-0. Epub 2021 Mar 4.
Impact factor: 30.7
Publication type: Paper in international publication
Authors: Silvio, Javier P, Scublinsky, Dario G, Bales, Alessandra, Catarino, Daniela, Fiss, Elie, Mohrbacher, Sara, Sato, Victor, Baylao, Antonio, Cavalcante, Adilson, Correa, Francini et al.
DOI: 10.1016/S2213-2600(21)00099-0

Publications

Publications searcher

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.

Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.

Safety and activity of the TGFbeta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.

Safety and activity of the TGFbeta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.

Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.

Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.

Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.

Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.

Safety, diagnostic, and therapeutic value of flexible bronchoscopy in critically ill COVID-19 patients.

Safety, diagnostic, and therapeutic value of flexible bronchoscopy in critically ill COVID-19 patients.

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.

Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.

Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.

Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

Patronage:

Collaborating:

Accreditations: